We will contact you about your insurance coverage.
If you’re eligible through your insurance plan, you can use Tandem Pump Rx to help you
get a Tandem insulin pump and supplies with:
Lower upfront costs
More predictable monthly payments for refill orders of infusion sets and cartridges
Home delivery
*$0 pump claim based on pump cost data for Tandem customers with pharmacy benefits (3/2/2026-7/31/2026). $0 pump supplies claim based on supply cost data for Tandem customers with pharmacy benefits and use of the Tandem copay card (3/2/2026-7/31/2026) Pump supplies cost calculation reflects the average monthly out-of-pocket cost for disposable infusion sets and cartridges necessary to utilize Tandem pump therapy and assumes consumption of 10 infusion sets and cartridges per month. The Tandem copay card has a maximum benefit of $100 per month for 12 months. Copays less than $100 will result in complete coverage for disposable infusion sets and cartridges only. The Tandem copay card is not available for customers on Kaiser, Medicare, Medicaid, or TRICARE plans. Additional terms and conditions apply. Actual cost may vary and is subject to individual's particular pharmacy benefits. Interested customers should contact Tandem for a free benefits check to determine actual cost for their situation.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.